Gehlert D R
Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285.
Life Sci. 1994;55(8):551-62. doi: 10.1016/0024-3205(94)00481-1.
Neuropeptide Y is a 36 amino acid peptide that was originally discovered in extracts of porcine brain. The peptide has a broad distribution in the central or peripheral nervous system. Receptors for this peptide were originally subdivided into postsynaptic Y-1 receptors and presynaptic Y-2 receptors. The Y-1 receptor has recently been cloned and appears to mediate several effects of NPY including vasoconstriction and an anxiolytic effect in animal models of anxiety. The Y-2 receptor inhibits the release of neurotransmitters in the CNS by the inhibition of the mobilization of intracellular calcium. Additional receptors have been proposed including a Y-3 receptor that recognizes NPY but not the related endocrine peptide, PYY. The functional importance of these newer receptors remains to be established. The absence of useful antagonists has made the study of NPY a challenge for investigators in the field. The potential utility of such molecules is discussed.
神经肽Y是一种由36个氨基酸组成的肽,最初是在猪脑提取物中发现的。该肽在中枢或外周神经系统中分布广泛。这种肽的受体最初被细分为突触后Y-1受体和突触前Y-2受体。Y-1受体最近已被克隆,似乎介导了神经肽Y的多种作用,包括血管收缩以及在焦虑动物模型中的抗焦虑作用。Y-2受体通过抑制细胞内钙的动员来抑制中枢神经系统中神经递质的释放。还提出了其他受体,包括识别神经肽Y但不识别相关内分泌肽PYY的Y-3受体。这些新受体的功能重要性仍有待确定。缺乏有效的拮抗剂使得神经肽Y的研究对该领域的研究人员来说是一项挑战。本文讨论了这类分子的潜在用途。